Ranking and prioritization of environmental risks of pharmaceuticals in surface waters
Tóm tắt
Từ khóa
Tài liệu tham khảo
Altenburger, 2003, Mixture toxicity and its modeling by quantitative structure–activity relationships, Environ. Toxicol. Chem., 22, 1900, 10.1897/01-386
Ashton, D., Kennedy, J., Thomas, K., Hilton, M., 2003. Evaluating the environmental risks of pharmaceuticals. Poster at SETAC 13th annual meeting Hamburg
ASTM, 1216, 1993. In: Gorsuch, J.W., Dwyer, F.J., Ingersoll, C.G., LaPoint, T.W. (Eds.), Environmental Toxicology and Risk Assessment, vol. 2, pp. 521–619. Section on SAR/QSAR in the Office of Pollution Prevention and Toxics. ASTM STP 1216, American Society for Testing and Materials, PA, USA
Boxall, 2003, Prioritization of veterinary medicines in the UK environment, Toxicol. Lett., 142, 207, 10.1016/S0378-4274(03)00067-5
Boxall, 2003, Are veterinary medicines causing environmental risks?, Environ. Sci. Technol., 37, 286, 10.1021/es032519b
Bradbury, 2003, Overview of data and conceptual approaches for deviation of Quantitative Structure-Activity Relationships for ecotoxicological effects of organic chemicals, Environ. Tox. Chem., 22, 1789, 10.1897/01-234
Canada, 2001. A Canadian perspective on the precautionary approach/principle, discussion document. http://www.pco-bcp.gc.ca/raoics-srdc/docs/precaution/Discussion/discussion_e.htm
Calamari, 2003, Stregic survey of therapeutic drugs in the rivers Po and Lambro in northern Italia, Environ. Sci. Technol., 37, 1241, 10.1021/es020158e
Calow, 2003, Does ecotoxicology inform ecological risk assessment?, Environ. Sci. Technol., 37, 147A, 10.1021/es0324003
Carlsen, L., 2003. An Introduction to QSAR for Regulatory Applications. Nordisk Ministerå, Copenhagen, Denmark, in press
CDER, 1998. Guidance for industry. Environmental assessment of human drug and biologics applications. USFDA. www.fda.gov/cder/guidance/index.htm
Christensen, 1998, Pharmaceuticals in the environment—A human risk?, Regul. Toxicol. Pharmacol., 28, 212, 10.1006/rtph.1998.1253
CLASSIC, 2002. In: Giddings, J.M. (Ed.), Community Level Aquatic System Studies—Interpretation Criteria. SETAC
Clark, 1995, Fugacity analysis and model of organic chemical fate in a sewage treatment plant, Environ. Sci. Technol., 29, 1488, 10.1021/es00006a009
Cleuvers, 2003, Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects, Toxicol. Lett., 142, 185, 10.1016/S0378-4274(03)00068-7
Cleuvers, M., 2004. Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid. Ecotoxicol. Environ. Saf., in press
Cunningham, V.L., Constable, D.C., 2002. Preliminary GSK model for estimating POTW removals for pharmaceutical compounds. Poster P-421, SETAC 23rd Annual Meeting in North America, 16–20 November, Salt Lake City Utah, US
Daughton, 1999, Special report. Pharmaceuticals and personal care products in the environment: agents of subtle change?, Environ. Health Perspect., 107, 907, 10.1289/ehp.99107s6907
Daughton, 2003, Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. 1. Rationale for and avenues toward a green pharmacy, Environ. Health Perspect., 111, 757, 10.1289/ehp.5947
Danish Board of Technology, 1996. The non-assessed chemicals in EU. Report 1996/5
DK-EPA, 2001. Report on the advisory list for selfclassification of dangerous substances. Environmental Project No. 636. Danish Environmental Protection Agency
EMEA, 2003. The European Agency for the Evaluation of Medicinal Products Pre-Authorization Evaluation of Medicines for Human Use. Committee for proprietary medicinal products, draft note for guidance on environmental risk assessment of medicinal products for human use. CPMP/SWP/4447/00 draft. www.emea.eu.int
Environmental Toxicology and Chemistry, 2003. In: Walker, J.D. (Ed.), Special Issue on QSAR, vol. 22, No. 8
Escher, 2002, Modes of action in ecotoxicology: their role in body burdens, species sensitivity, QSARs and mixture effects. A critical review, Environ. Sci. Technol., 36, 4201, 10.1021/es015848h
EU, 2000. Communication from the commission on the precautionary principle. COM (2000) 1. Brussels 2/2-2000. http://europa.eu.int/eur-lex/en/com/cnc/2000/com2000_0001en01.pdf
EU, 2001a. CSTEE. Discussion paper on environmental risk assessment of medical products for human use (non-genetically modified organisms (non-GMO) containing). CPMPpaperRAssessHumPharm12062001/D(01). Brussels, Belgium
EU, 2001b. White paper. Strategy for a future chemicals policy, COM (2001) 88 Final. http://europa.eu.int/comm/environment/chemicals/0188_16en.pdf (accessed 08-08-03)
EU, 2001c. Communication from the commission on a community strategy against antimicrobial resistance. http://europa.eu.int/comm/health/ph/others/antimicrob_resist/am_02_en.pdf (accessed 08-08-03)
EU, 2002. EU Food Law News (02-137) Commission press release (IP/02/1891), 16-12-02. Council backs prohibition of antibiotics as growth promoters: Byrne welcomes political agreement on feed additives. http://www.foodlaw.rdg.ac.uk/news/eu-02137.htm (accessed 08-08-03).
FDA, 1995. Centre for drug evaluation and research (CDER). Guidance for industry for the submission of an environmental assessment in human drug applications and supplements, Food and Drug Administration, 1995
Halling-Sørensen, 1998, Occurrence, fate and effects of pharmaceutical substances in the environment—a review, Chemosphere, 36, 357, 10.1016/S0045-6535(97)00354-8
Heberer, 2002, Occurrence, fate, and removal of pharmaceutical residues in the aquatic envionment: a review of recent research data, Toxicol. Lett., 131, 5, 10.1016/S0378-4274(02)00041-3
Hirsch, 1999, Occurrence of antibiotics in the aquatic environment, Sci. Total Environ., 225, 109, 10.1016/S0048-9697(98)00337-4
Hornbaker, 2003, The precautionary principle in practice: applying the Ashford framework to technological risk, Hum. Ecol. Risk Assess., 9, 789, 10.1080/713609967
Howard, P.H., 1998. User’s guide for the SMILES CAS program. http://esc.syrres.com/interkow/docsmile.htm (0707-2003)
Jones, 2001, Human pharmaceuticals in the aquatic environment—a review, Environ. Technol., 22, 1383, 10.1080/09593332208618186
Jones, 2002, Aquatic environmental assessment of the top 25 English prescription pharmaceuticals, Water Res., 36, 5013, 10.1016/S0043-1354(02)00227-0
Jørgensen, 2000, Editorial: drugs in the environment, Chemosphere, 40, 691, 10.1016/S0045-6535(99)00438-5
Kaiser, 1999, A note of caution to users of ECOSAR, Water Qual. Res. J. Can., 34, 179, 10.2166/wqrj.1999.006
Klopman, 2000, Multiple computer-automated structure evaluation study of aquatic toxicity II. Fathead minnow, Environ. Toxicol. Chem., 19, 441, 10.1002/etc.5620190225
Kolpin, 2002, Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S streams, 1999–2000: a national reconnaissance, Environ. Sci. Technol., 36, 1202, 10.1021/es011055j
Kümmerer, 2001, Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources—a review, Chemosphere, 45, 957, 10.1016/S0045-6535(01)00144-8
Lam, M.W., Young, C.J., Brain, R.A., Johnson, D.J., Hanson, M.A., Wilson, C.J., Richards, S.M., Solomon, K.R., Mabury, S.A., 2003. The aquatic persistence of eight pharmaceuticals in outdoor microcosms monitored by HPLC-UV and LC–MS-MS using electrospray ionization. Environ. Toxicol. Chem., in press
Martindale, 2002. In: Sweetman, S.C. (Ed.), Martindale, The Complete Drug Reference, 33rd ed. Pharmaceutical Press Chicago, USA, 2483 pp
Meyland, 1998
Meyland, 1999
Montsford, 1999, The exposure assessment of veterinary medicinal products, Sci. Tot. Env., 225, 119, 10.1016/S0048-9697(98)00338-6
Moore, 2003, A comparison of model performance for six quantitative structure–activity relationship packages that predict acute toxicity to fish, Environ. Toxicol. Chem., 22, 1799, 10.1897/00-361
Nabholz, V.J., Clements, R.G., Zeeman, M.G., Osborn, K.C., Wedge, R., 1993. Validation of structure activity relationships used by the USEPA’s office of pollution prevention and toxics for the environmental hazard assessment of industrial chemicals. In: Gorsuch, J.W., Dwyer, F.J., Ingersoll, C.G., LaPoint, T.W. (Eds.), Environmental Toxicology and Risk Assessment, vol. 2, ASTM, 1216. 1993. ASTM STP 1216, American Society for Testing and Materials, PA, USA, pp. 571–591
Nabholz, V.J., 2001. SAR validation study. Poster Presentation at Society of Toxicology annual meeting March 2001 in San Francisco, USA
Nawaz, 2001, Human health impact and regulatory issuses involving antimicrobial resistance in the food animal production environment, Reg. Res. Persp., 1, 10
NSF, 2003. A 10-year outlook for the United States National Science Foundation: Complex environmental systems, synthesis for earth, life, and society in the 21st century. http://www.nsf.gov/geo/ere/ereweb/acere_synthesis_rpt.cfm (accessed 08-08-03)
Rapport, 2002, The health of ecology and the ecology of health, Hum. Ecol. Risk Assess., 8, 205, 10.1080/20028091056836
Reddersen, 2002, Identification and significance of phenazone drugs and their metabolites in ground- and drinking water, Chemosphere, 49, 539, 10.1016/S0045-6535(02)00387-9
Ren, 2003, Ecotoxicity prediction using mechanism- and non-mechanism-based QSARs: a preliminary study, Chemosphere, 53, 1053, 10.1016/S0045-6535(03)00573-3
Richardson, 1985, The fate of pharmaceutical chemicals in the aquatic environment—a review, J. Pharm. Pharmacol., 37, 1, 10.1111/j.2042-7158.1985.tb04922.x
Salvito, 2002, A framework for prioritizing fragrance materials for aquatic risk assessment, Environ. Toxicol. Chem., 21, 1301, 10.1002/etc.5620210627
Sanderson, 2002, Power analysis as a reflexive scientific tool for interpretation and implementation of the precautionary principle in the European Union, Environ. Sci. Pollut. Res., 9, 221, 10.1007/BF02987494
Sanderson, H., 2002. Design, analysis and interpretation of higher tier risk assessment of chemicals in aquatic microcosms. Doctoral dissertation, University of Roskilde, Denmark. http://www.ruc.dk/teksam/phdinfo/hans (accessed 08-08-03)
Sanderson, 2003, Probabilistic hazard assessment of environmentally ccurring pharmaceuticals acute toxicity to fish, daphnids and algae by ECOSAR screening, Toxicol. Lett., 144, 383, 10.1016/S0378-4274(03)00257-1
Sanderson, H., Dyer, S., Nabholz, V.J., 2004. QSAR’s and extrapolation. In: Solomon, KR., Sibley, PL., Sanderson, H., Richards, SM., Dyer, S., Brock, TCM., van den Brink, P., Posthuma, L., de Zwart, D., Extrapolation practice for ecological effect characterization of chemicals (EXPECT), SETAC Press, In prep
Schmieder, 2003, Quantitative structure–activity relation models for prediction of estrogen receptor binding affinity of structurally diverse chemicals, Environ. Toxicol. Chem., 22, 1844, 10.1897/01-345
Seiler, 2002, Pharmacodynamic activity of drugs and ecotoxicology—can the two be connected?, Toxicol. Lett., 131, 105, 10.1016/S0378-4274(02)00045-0
Straub, 2002, Environmental risk assessment for new human pharmaceuticals in the Euorpean Union according to the draft guideline/discussion paper of January 2001, Toxicol. Lett., 131, 137, 10.1016/S0378-4274(02)00049-8
Stuer-Lauridsen, F., Hansen, L., Birkved, M., Kjølholt, J., Mikkelsen, S., 2002. Litteraturudredning vedrørende human medicin i miljøet. Miljøprojekt Nr. 661. Danish EPA
Tong, 2002, Development of quantitative structure–activity relations (QSARs) and their use for priority setting in the testing strategy of endocrine disruptors, Reg. Res. Perspect., 1, 1
US Federal Register, 1999. Category for persistent, bioaccumulation and toxic new chemical substances, Environmental Protection Agency, vol. 64, No. 213, November 4, p. 60198
Weigel, 2003, Genetic analysis of a high-level Vancomycin-resistant isolate of Stphylococcus aureus, Science, 302, 1569, 10.1126/science.1090956
WHO, 1997. The medical impact of antimicrobial use in food animals. World Health Organization emerging and other communicable diseases, surveillance and control. Berlin, Germany